Zorubicin HCl
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 413482

CAS#: 36508-71-1 (HCl)

Description: Zorubicin HCl is an Antineoplastic

Chemical Structure

img
Zorubicin HCl
CAS# 36508-71-1 (HCl)
Instruction

Theoretical Analysis

MedKoo Cat#: 413482
Name: Zorubicin HCl
CAS#: 36508-71-1 (HCl)
Chemical Formula: C34H36ClN3O10
Exact Mass: 0.00
Molecular Weight: 682.120
Elemental Analysis: C, 59.87; H, 5.32; Cl, 5.20; N, 6.16; O, 23.45

Price and Availability

Size Price Availability Quantity
10mg USD 280 2 Weeks
20mg USD 465 2 Weeks
50mg USD 835 2 Weeks
100mg USD 1365 2 Weeks
Bulk inquiry

Related CAS #: 36508-71-1 (HCl)   54083-22-6 (free base)    

Synonym: Zorubicin HCl; NSC164011; NSC-164011; NSC 164011

IUPAC/Chemical Name: N'-((E)-1-((2S,4S)-4-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-2-yl)ethylidene)benzohydrazide hydrochloride

InChi Key: NKFHKYQGZDAKMX-PPRKPIOESA-N

InChi Code: InChI=1S/C34H35N3O10.ClH/c1-15-28(38)20(35)12-23(46-15)47-22-14-34(44,16(2)36-37-33(43)17-8-5-4-6-9-17)13-19-25(22)32(42)27-26(30(19)40)29(39)18-10-7-11-21(45-3)24(18)31(27)41;/h4-11,15,20,22-23,28,38,40,42,44H,12-14,35H2,1-3H3,(H,37,43);1H/b36-16+;/t15-,20-,22-,23-,28+,34-;/m0./s1

SMILES Code: COc1c2c(C(c3c(C2=O)c(O)c4c(C[C@](C[C@@H]4O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O)N)(/C(C)=N/NC(c6ccccc6)=O)O)c3O)=O)ccc1.Cl

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: To be determined

Shelf Life: >2 years if stored properly

Drug Formulation: to be determined

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Solubility Data

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
To be determined 0.0 100.00

Preparing Stock Solutions

The following data is based on the product molecular weight 682.12 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Deng S, Cui CX, Duan L, Hu L, Yang X, Wang JC, Qu LB, Zhang Y. Anticancer Drug Release System Based on Hollow Silica Nanocarriers Triggered by Tumor Cellular Microenvironments. ACS Omega. 2020 Dec 29;6(1):553-558. doi: 10.1021/acsomega.0c05032. PMID: 33458507; PMCID: PMC7807753.

2: Poochikian GK, Cradock JC, Flora KP. Stability of anthracycline antitumor agents in four infusion fluids. Am J Hosp Pharm. 1981 Apr;38(4):483-6. PMID: 6945043.

3: Jaiyesimi IA, Kantarjian HM, Estey EH. Advances in therapy for hairy cell leukemia. A review. Cancer. 1993 Jul 1;72(1):5-16. doi: 10.1002/1097-0142(19930701)72:1<5::aid-cncr2820720104>3.0.co;2-y. PMID: 7685243.

4: Alberts DS, Van Daalen Wetters T. Rubidazone vs adriamycin: an evaluation of their differential toxicity in the spleen colony assay system. Br J Cancer. 1976 Jul;34(1):64-8. doi: 10.1038/bjc.1976.123. PMID: 952715; PMCID: PMC2025119.